Mitraclip therapy in patients with functional mitral regurgitation and missing leaflet coaptation: is it still an exclusion criterion?
暂无分享,去创建一个
M. Metra | S. Curello | F. Ettori | C. Fiorina | C. Lombardi | R. Rovetta | M. Adamo | G. Chizzola | Elena Pezzotti | E. Chiari | A. Manzato | G. Cuminetti | Cristian Maiandi | M. Frontini
[1] D. Burkhoff,et al. Long-term survival after MitraClip(®) therapy in patients with severe mitral regurgitation and severe congestive heart failure: A comparison among survivals predicted by heart failure models. , 2016, Journal of cardiology.
[2] A. Triantafyllis,et al. Long‐term survival and preprocedural predictors of mortality in high surgical risk patients undergoing percutaneous mitral valve repair , 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[3] G. Filippatos,et al. Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions: A Consensus Document From the Mitral Valve Academic Research Consortium. , 2015, Journal of the American College of Cardiology.
[4] H. Ince,et al. Meta-analysis of the usefulness of Mitraclip in patients with functional mitral regurgitation. , 2015, The American journal of cardiology.
[5] D. Capodanno,et al. Predictors of clinical outcomes after edge-to-edge percutaneous mitral valve repair. , 2015, American heart journal.
[6] M. Metra,et al. Effectiveness of MitraClip therapy in patients with refractory heart failure. , 2015, Journal of interventional cardiology.
[7] D. Capodanno,et al. Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry. , 2015, JACC. Cardiovascular interventions.
[8] Antonio Colombo,et al. Clinical outcomes of MitraClip for the treatment of functional mitral regurgitation. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[9] S. Blankenberg,et al. Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry. , 2014, Journal of the American College of Cardiology.
[10] S. Blankenberg,et al. MitraClip therapy in surgical high-risk patients: identification of echocardiographic variables affecting acute procedural outcome. , 2014, JACC. Cardiovascular interventions.
[11] Patric Biaggi,et al. Two-year outcomes after percutaneous mitral valve repair with the MitraClip system: durability of the procedure and predictors of outcome , 2014, Open Heart.
[12] Christian Butter,et al. Percutaneous interventional mitral regurgitation treatment using the Mitra-Clip system , 2014, Clinical Research in Cardiology.
[13] R. Siegel,et al. Peri-interventional echo assessment for the MitraClip procedure. , 2013, European heart journal cardiovascular Imaging.
[14] J. Hausleiter,et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. , 2013, Journal of the American College of Cardiology.
[15] E. Foster,et al. 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. , 2013, Journal of the American College of Cardiology.
[16] S. Blankenberg,et al. Aetiology of mitral regurgitation differentially affects 2‐year adverse outcomes after MitraClip therapy in high‐risk patients , 2013, European journal of heart failure.
[17] D. Capodanno,et al. One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry). , 2013, The American journal of cardiology.
[18] C. Nienaber,et al. Use of four MitraClip devices in a patient with ischemic cardiomyopathy and mitral regurgitation , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[19] O. Alfieri,et al. Guidelines on the management of valvular heart disease (version 2012). , 2012, European heart journal.
[20] Juerg Schwitter,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.
[21] O. Alfieri,et al. Guidelines on the management of valvular heart disease. , 2007, European heart journal.
[22] K. Kuck,et al. MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry , 2012, European journal of heart failure.
[23] Hiroyuki Okura,et al. Influence of chronic tethering of the mitral valve on mitral leaflet size and coaptation in functional mitral regurgitation. , 2012, JACC. Cardiovascular imaging.
[24] Falk,et al. Kommentar zu den gemeinsamen "Guidelines on myocardial revascularization" der European Society of Cardiology (ESC) und der European Association for Cardio-Thoracic Surgery (EACTS) , 2012, Zeitschrift für Herz-,Thorax- und Gefäßchirurgie.
[25] T. Meinertz,et al. MitraClip® therapy in patients with end‐stage systolic heart failure , 2011, European journal of heart failure.
[26] J. Gorman,et al. Percutaneous repair or surgery for mitral regurgitation. , 2011, The New England journal of medicine.
[27] Laura Mauri,et al. The EVEREST II Trial: design and rationale for a randomized study of the evalve mitraclip system compared with mitral valve surgery for mitral regurgitation. , 2010, American heart journal.
[28] H. Reichenspurner,et al. Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. , 2010, European heart journal.
[29] G. Filippatos,et al. [Guidelines on the management of valvular heart disease]. , 2013, Revista espanola de cardiologia.
[30] E. Foster,et al. Quantitative assessment of severity of mitral regurgitation by serial echocardiography in a multicenter clinical trial of percutaneous mitral valve repair. , 2007, The American journal of cardiology.
[31] J. Mirelis,et al. Guidelines on the management of valvular heart disease. , 2007, European heart journal.
[32] Helmut Baumgartner,et al. Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology , 2007 .